Russell Investments Group, Ltd. Gossamer Bio, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$0.8 - $1.51 $3,765 - $7,107	4,707 Added 38.58%	16,907 $19,000
Q4 2023 Feb 05, 2024	BUY	$0.48 - $1.08 $2,591 - $5,830	5,399 Added 79.39%	12,200 $11,000
Q3 2023 Nov 13, 2023	SELL	$0.78 - $1.82 $3,777 - $8,814	-4,843 Reduced 41.59%	6,801 $5,000
Q2 2023 Aug 10, 2023	BUY	$0.98 - $1.53 $6,664 - $10,405	6,801 Added 140.43%	11,644 $13,000
Q1 2023 May 09, 2023	BUY	$0.96 - $2.92 $2,394 - $7,282	2,494 Added 106.17%	4,843 $6,000
Q4 2022 Feb 08, 2023	SELL	$1.74 - $12.87 $63,812 - $471,994	-36,674 Reduced 93.98%	2,349 $5,000
Q3 2022 Nov 04, 2022	BUY	$7.21 - $14.88 $253,972 - $524,148	35,225 Added 927.46%	39,023 $466,000
Q2 2022 Jul 29, 2022	SELL	$5.97 - $9.97 $219,719 - $366,935	-36,804 Reduced 90.65%	3,798 $31,000
Q1 2022 May 05, 2022	SELL	$8.44 - $12.49 $109,154 - $161,533	-12,933 Reduced 24.16%	40,602 $351,000
Q4 2021 Jan 21, 2022	SELL	$10.12 - $14.07 $189,962 - $264,107	-18,771 Reduced 25.96%	53,535 $604,000
Q3 2021 Nov 08, 2021	SELL	$7.25 - $13.23 $63,749 - $116,331	-8,793 Reduced 10.84%	72,306 $908,000
Q2 2021 Aug 04, 2021	SELL	$8.0 - $9.75 $52,200 - $63,618	-6,525 Reduced 7.45%	81,099 $658,000
Q1 2021 May 10, 2021	SELL	$8.63 - $10.94 $72,492 - $91,896	-8,400 Reduced 8.75%	87,624 $809,000
Q4 2020 Feb 08, 2021	SELL	$8.3 - $13.59 $180,317 - $295,242	-21,725 Reduced 18.45%	96,024 $928,000
Q3 2020 Nov 09, 2020	BUY	$11.3 - $14.75 $546,343 - $713,147	48,349 Added 69.67%	117,749 $1.46 Million
Q2 2020 Aug 05, 2020	BUY	$9.52 - $15.98 $614,801 - $1.03 Million	64,580 Added 1339.83%	69,400 $900,000
Q1 2020 May 06, 2020	SELL	$8.0 - $15.48 $211,848 - $409,925	-26,481 Reduced 84.6%	4,820 $48,000
Q4 2019 Jan 29, 2020	BUY	$14.82 - $26.79 $463,880 - $838,553	31,301 New	31,301 $487,000

Others Institutions Holding GOSS

# of Institutions

108

Shares Held

167M

Call Options Held

430K

Put Options Held

519K

Nea Management Company, LLC Timonium, MD

18.1M
Shares

$17.9 Million
1.37% of portfolio
Siren, L.L.C. New York, NY

13.3M
Shares

$13.1 Million
0.65% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$11.6 Million
0.0% of portfolio
Octagon Capital Advisors LP New York, NY

9.19M
Shares

$9.1 Million
2.2% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$7.98 Million
4.79% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $93M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account